UK markets close in 24 minutes

Exicure, Inc. (XCUR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5051-0.0099 (-1.92%)
As of 10:58AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.45M
Enterprise value 9.12M
Trailing P/E 0.29
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.13
Price/book (mrq)0.46
Enterprise value/revenue 0.38
Enterprise value/EBITDA 1.81

Trading information

Stock price history

Beta (5Y monthly) 1.23
52-week change 3-42.78%
S&P500 52-week change 322.64%
52-week high 31.5000
52-week low 30.3650
50-day moving average 30.6185
200-day moving average 30.6963

Share statistics

Avg vol (3-month) 3221.74k
Avg vol (10-day) 363.25k
Shares outstanding 58.65M
Implied shares outstanding 69.07M
Float 87.81M
% held by insiders 145.04%
% held by institutions 19.80%
Shares short (15 Apr 2024) 4151.66k
Short ratio (15 Apr 2024) 47.4
Short % of float (15 Apr 2024) 42.01%
Short % of shares outstanding (15 Apr 2024) 41.75%
Shares short (prior month 15 Mar 2024) 4183.38k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:30
Last split date 330 Jun 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 12.88%
Operating margin (ttm)13.48%

Management effectiveness

Return on assets (ttm)7.36%
Return on equity (ttm)56.40%

Income statement

Revenue (ttm)23.79M
Revenue per share (ttm)3.86
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA 4.26M
Net income avi to common (ttm)3.06M
Diluted EPS (ttm)1.7700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.33M
Total cash per share (mrq)0.27
Total debt (mrq)7M
Total debt/equity (mrq)72.12%
Current ratio (mrq)2.56
Book value per share (mrq)1.12

Cash flow statement

Operating cash flow (ttm)-21.95M
Levered free cash flow (ttm)-11.54M